Harrow expands board to six members, appoints Dr. Adrienne Graves and Lauren Silvernail

HARROW, INC.

Board size increased from 4 to 6 members effective January 26, 2024.
Dr. Adrienne Graves brings ophthalmology expertise as former CEO of Santen Inc. and board member at multiple eye-care firms.
Lauren Silvernail brings financial and strategic expertise as former CFO of Evolus, Revance, and ISTA Pharmaceuticals.
Appointments are effective immediately; press release issued January 29, 2024.
Neither new director has been assigned to a board committee at this time.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Lauren P. Silvernail

Director

HROW · HARROW, INC.

Effective: 2024-01-26
Filed: January 29, 2024, 6:59 PM ET

On January 26, 2024 (the “Effective Date”), the board of directors (the “Board”) of Harrow, Inc. (the “Company”), following the recommendation of the Nomination and Corporate Governance Committee of the Board, expanded the size of the Board from four members to six and elected Adrienne L. Graves, Ph.D. and Lauren P. Silvernail to serve as members of the Board, effective immediately.

Appointed

Adrienne L. Graves

Director

HROW · HARROW, INC.

Effective: 2024-01-26
Filed: January 29, 2024, 6:59 PM ET

On January 26, 2024 (the “Effective Date”), the board of directors (the “Board”) of Harrow, Inc. (the “Company”), following the recommendation of the Nomination and Corporate Governance Committee of the Board, expanded the size of the Board from four members to six and elected Adrienne L. Graves, Ph.D. and Lauren P. Silvernail to serve as members of the Board, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Lauren P. Silvernail was elected as Director at HARROW, INC..

Action: elected
Role: Director

Exact text from the filing

On January 26, 2024 (the “Effective Date”), the board of directors (the “Board”) of Harrow, Inc. (the “Company”), following the recommendation of the Nomination and Corporate Governance Committee of the Board, expanded the size of the Board from four members to six and elected Adrienne L. Graves, Ph.D. and Lauren P. Silvernail to serve as members of the Board, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Adrienne L. Graves was elected as Director at HARROW, INC..

Action: elected
Role: Director

Exact text from the filing

On January 26, 2024 (the “Effective Date”), the board of directors (the “Board”) of Harrow, Inc. (the “Company”), following the recommendation of the Nomination and Corporate Governance Committee of the Board, expanded the size of the Board from four members to six and elected Adrienne L. Graves, Ph.D. and Lauren P. Silvernail to serve as members of the Board, effective immediately.

View on SEC.gov

HARROW, INC. filing history →

Source: SEC EDGAR

accession 0001493152-24-004161

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.